Skip to content

Opening book details…

About this Medicine article

Safety and Efficacy of the 2.25-mm Sirolimus-Eluting Bx Velocity Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions: the SIRIUS 2.25 Trial by Jeffrey W. Moses; Eugenia Nikolsky; Roxana Mehran; Patrick A. Cambier; William B. Bachinsky; Fred Leya; Richard E. Kuntz; Jeffrey J. Popma; Patricia Schleckser; Hong Wang; Sidney A. Cohen; Martin B. Leon is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Jeffrey W. Moses; Eugenia Nikolsky; Roxana Mehran; Patrick A. Cambier; William B. Bachinsky; Fred Leya; Richard E. Kuntz; Jeffrey J. Popma; Patricia Schleckser; Hong Wang; Sidney A. Cohen; Martin B. Leon
Publisher
Elsevier Science; Elsevier ; Elsevier Inc.; Elsevier BV (ISSN 0002-9149)
Published
2006
Field
Medicine (Health Sciences)

More by Jeffrey W. Moses; Eugenia Nikolsky; Roxana Mehran; Patrick A. Cambier; William B. Bachinsky; Fred Leya; Richard E. Kuntz; Jeffrey J. Popma; Patricia Schleckser; Hong Wang; Sidney A. Cohen; Martin B. Leon

Browse all works by Jeffrey W. Moses; Eugenia Nikolsky; Roxana Mehran; Patrick A. Cambier; William B. Bachinsky; Fred Leya; Richard E. Kuntz; Jeffrey J. Popma; Patricia Schleckser; Hong Wang; Sidney A. Cohen; Martin B. Leon